Abstract
Aging signals a gradual deregulation of physiological homeostasis. Steroid hormone actions are an important contributor to this deregulation because of their key involvements in the growth, metabolism, survival, and functional vigor of cells, tissues, and organs. Accumulated evidences show that aging is associated with reduced circulating levels of male and female sex hormones, i.e., androgens and estrogens, respectively, which in turn alter physiological milieu and lead to specific deficits in the organismal vitality. While a number of articles in the literature have provided a generalized description of age-related decline of physiological control mechanisms, in the current chapter, we have focused specifically on the role of sex hormones and sex steroid receptors in age-related bodily dysfunctions. Various segments of our article delved into the current understanding on influences of sex steroids and steroid receptors. Specifically, the roles of androgens, estrogens, and cognate sex steroid receptors in age-accompanied physiological and pathophysiological changes in gene expression and organ functions are discussed. In addition to citing our own studies, information from diverse fields of biology and medicine is taken into consideration in order to present a comprehensive view of sex steroid action with advancing age.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zajacic-Rotkvic V, Kavur L, Maja C-B (2010) Hormones and aging. Acta Clin Croat 49:549–554
Horstman AM, Gerrits KH, Beltman MJ, Koppe PA, Janssen TW, de Haan A (2010) Intrinsic properties of the knee extensor muscles after subacute stroke. Arch Phys Med Rehabil 91:123–128
Zaidi KS, Shen W-Z, Azhar S (2012) Impact of aging on steroid hormone biosynthesis and Secretion. Open Longevity Sci 6:1–30
Eskin BA (1978) Sex hormones and aging. Adv Exp Med Biol 97:207–224
Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 321:81–151
Kallen CB (2004) Steroid hormone synthesis in pregnancy. Obstet Gynecol Clin N Am 31:795–816
Arlt W, Stewart PM (2005) Adrenal corticosteroid biosynthesis, metabolism and action. Endocrinol Metab Clin N Am 34:293–313
Kendall B, Eston R (2002) Exercise-induced muscle damage and the potential protective role of estrogen. Sports Med 32:103–123
Goodman-Gruen D, Barrett-Connor E (2000) Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23:912–918
Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M (2012) The Role of Androgens and Estrogens on Healthy Aging and Longevity. J Gerontol A Biol Sci Med Sci 67:1140–1152
Kumar S, Saradhi M, Chaturvedi NK, Tyagi RK (2006) Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview review. Mol Cell Endocrinol 246:147–156
Kumar S, Kumar S, Thakur K, Kumar S, Bagchi G, Tyagi RK (2016) Androgen receptor signaling by growth factors in androgen-independent prostate cancer: recent advances and emerging perspectives. In: Haldar C, Gupta S, Goswami S (eds) Updates on integrative physiology and comparative endocrinology. Press and Publication Division, Banaras Hindu University, Varanasi. ISBN: 81-85305-72-2
Tyagi RK, Lavrovsky Y, Ahn SC, Song CS, Chatterjee B, Roy AK (2000) Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol 14:1162–1174
Htun H, Holth LT, Walker D, Davie JR, Hager GL (1999) Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell 10:471–486
Roy AK, Tyagi RK, Song CS, Lavrovsky Y, Ahn SC, Oh TS, Chatterjee B (2001) Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction. Ann NY Acad Sci 949:44–57
Dehm S, Tindall D (2011) Alternatively spliced androgen receptor variants. Endocrine Relat Cancer 18:R183–R196
Evans RM, Mangelsdorf DJ (2014) Nuclear receptors, RXR and the big bang. Cell 157:255–266
Ni L, Llewellyn R, Kesler CT, Kelley JB, Spencer A, Snow CL, Shank L, Paschal BM (2013) Androgen Induces a Switch from Cytoplasmic Retention to Nuclear Import of the Androgen Receptor. Mol Cell Biol 33:4766–4778
Cato L, Neeb A, Brown M, Cato ACB (2014) Control of steroid receptor dynamics and function by genomic actions of the cochaperones p23 and Bag-1L. Nucl Recept Signal 12:e005. https://doi.org/10.1621/nrs.12005
Rivera OJ, Song CS, Centonze VE, Lechleiter JD, Chatterjee B, Roy AK (2003) Role of the PML body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells. Mol Endocrinol 17:128–140
Rosenfeld MG, Lunyak VV, Glass CK (2006) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405–1418
Cai C, Yuan X, Balk SP (2013) Androgen receptor epigenetics. Transl Androl Urol 2:148–157
Zhang A, Zhao JC, Kim J, Chakravarti D, Mo YY, Yu J (2015) LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep 13:209–221
Pascal LE, Wang Z (2014) Unzipping androgen action through ZIP9: a novel membrane androgen receptor. Endocrinol 155:4120–4123
Bagchi G, Wu J, French J, Kim J, Moniri NH, Daaka Y (2008) Androgens transduce the Gαs-mediated activation of protein kinase A in prostate cells. Cancer Res 68(9). https://doi.org/10.1158/0008-5472
Dagar M, Bagchi G (2015) Cross talk between protein kinase A and androgen signaling pathway. J Endocrinol Reprod 19:1–6
Zhou J, Richardson M, Reddy V, Menon M, Barrack ER, Reddy GP, Kim SH (2013) Structural and functional association of androgen receptor with telomeres in prostate cancer cells. Aging 5:3–17
Ma W-L, Lai H-C, Yeh S, Cai X, Chang C (2014) Androgen receptor roles in hepatocellular carcinoma, cirrhosis, and hepatitis. Endocr Relat Cancer 21:R165–R182
Lin H-Y, Yu I-C, Wang R-S, Chen Y-T, Liu N-C, Altuwaijri S, Hsu CL, Ma W-L, Jokinen J, Sparks JD, Yeh S, Chang C (2008) Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 47:1924–1935
Song CS, Jung MH, Kim SC, Hassan T, Roy AK, Chatterjee B (1998) Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter. J Biol Chem 273:21856–21866
Prakash CP, Zuniga B, Song CS, Jiang S, Cropper JD, Park S, Chatterjee B (2015) Nuclear receptors in drug metabolism, drug response and drug interactions. Nucl Recept Res 2:1–20
Kanda T, Yokosuka O (2015) The androgen receptor as an emerging target in hepatocellular carcinoma. J Hepatocell Carcinoma 2:91–99
Kemp CJ, Leary CN, Drinkwater NR (1989) Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous. Proc Natl Acad Sci USA 86:7505–7509
Ma W-L, Hsu C-L, Yeh C-C, Wu M-H, Huang C-K, Jeng L-B, Hung Y-C, Lin T-Y, Yeh S, Chang C (2012) Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology 56:176–185
Shi LH, Ko S, Kim S, Echchgadda I, Oh T, Song CS, Chatterjee B (2008) Reciprocal synamics of the tumor suppressor p53 and poly(ADP-ribose)polymerase PARP-1 regulates loss of androgen receptor in aging and oxidative stress. J Biol Chem 283:36474–36485
Song CS, Rao TR, Demyan WF, Mancini MA, Chatterjee B, Roy AK (1991) Androgen receptor messenger ribonucleic acid (mRNA) in the rat liver: changes in mRNA levels during maturation, aging, and calorie restriction. Endocrinol 128:349–356
Chatterjee B, Fernandes G, Yu BP, Song C, Kim JM, Demyan W, Roy AK (1989) Calorie restriction delays age-dependent loss in androgen responsiveness of the rat liver. FASEB J 3:169–173
Roy AK, Oh T, Rivera O, Mubiru J, Song CS, Chatterjee B (2002) Impacts of transcriptional regulation on aging and senescence. Ageing Res Rev 1:367–380
Supakar PC, Song CS, Jung MH, Slomczynska MA, Kim JM, Vellanoweth RL, Chatterjee B, Roy AK (1993) A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene. J Biol Chem 268:26400–26408
Supakar PC, Jung MH, Song CS, Chatterjee B, Roy AK (1995) Nuclear factor кB functions as a negative regulator for the rat androgen receptor gene and NF-кB activity increases during the age-dependent desensitization of the liver. J Biol Chem 270:837–842
Ko SY, Shi LH, Song CS, Chatterjee B (2008) Interplay of NF-кB and B-myb in TNFα-controlled negative regulation of androgen receptor expression. Mol Endocrinol 22:273–286
Lavorvsky Y, Chatterjee B, Clark RA, Roy AK (2000) Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 35:521–532
Kraus WL, Lis JT (2003) PARP goes transcription. Cell 113:677–683
Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Guarente L, Auwerx J et al (2013) The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154:430–441
Gomes AP, Price NL, Ling AJY, Moslehi JJ, Montgomery MK, Rajman L, Bell EL, Sinclair DA et al (2013) Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155:1624–1638
Li J, Bonkowski MS, Moniot S, Zhang D, Hubbard BP, Ling AJY, Steegborn C, Sinclair DA et al (2017) A conserved NAD+ binding pocket that regulates protein-protein interactions during aging. Science 355:1312–1317
Prins GS, Jung MH, Vellanoweth RL, Chatterjee B, Roy AK (1996) Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia. Dev Genet 18:99–106
Cunha GR (1996) Growth factors as mediators of androgen action during male urogenital development. Prostate 6:22–25
Shi X, Gippi J, Dries M, Bushman W (2014) Prostate progenitor cells proliferate in response to castration. Stem Cell Res 13:154–163
Vignozzi L, Gacci M, Maggi M (2016) Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol 13:108–119
Vital P, Castro P, Tsang S, Ittmann M (2014) The senescence-associated secretory phenotype promotes benign prostatic hyperplasia. Am J Pathol 184:721–733
Coppé J-P, Desprez P-Y, Krtolical A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Ann Rev Pathol 5:99–118
Begley L, Monteleon C, Shah RB, MacDonald JW, Macoska JA (2005) CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro. Aging Cell:291–298
Harshman LC, Wang X, Nakabayashi M, Xie W, Valenca L, Werner L, Yu Y, Kantoff AM, Sweeney CJ, Mucci LA, Pomerantz M, Lee GM, Kantoff PW (2015) Statin use at the time of initiation of androgen deprivation therapy and time to progression in patients with hormone-sensitive prostate cancer. JAMA Oncol:0829
Cai C, Chen S, Ng P, Bubley GJ, Nelson PS, Mostaghel EA, Marck B et al (2011) Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cancer Res 71:6503–6513
de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S et al (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364:1995–2005
Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, de Wit R, Mulders P, Chi KN, Shore ND, Armstrong AJ, Flaig TW, Fléchon A et al (2012) Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 367:1187–1197
Nieschlag E, Behre HM, Nieschlag S. Andrology (2001) Male reproductive health and dysfunction, 3rd ed. Springer
Arianayagam R, Arianayagam M, McGrath S, Rashid P (2010) Androgen deficiency in the aging man. Aust Fam Physician 39:752–755
MacDonald PC. 1976. Origin of estrogen in men. In: Benign prostatic hyperplasia. DHEW Publication No. (NIH) 76–1113.
Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrin Metab 86:724–731
Chen W, Hunt DM, Lu H, Hunt RC (1999) Expression of antioxidant protective proteins in the rat retina during prenatal and postnatal development. Invest Ophthalmol Vis Sci 40:744–751
Zirkin BR, Chen H (2000) Regulation of Leydig cell steroidogenic function during aging. Biol Reprod 63:977–981
Stanworth RD, Hugh Jones T (2008) Testosterone for the aging male; current evidence and recommended practice. Clinical Interv Aging 3:25–44
Vermeulen A, Rubens R, Verdonck L (1972) Testosterone secretion and metabolism in male senescence. J Clin Endocr 34:730
Vermeulon A (1995) Declining androgens with age: an overview. In: Vermeulon A, Oddens BJ, International Health Foundation (eds) Androgens and the aging male. Parthenon Publishing, New York, pp 3–14
Simon D, Nahoul K, Charles MA. 1996. Sex hormones, aging, ethnicity and insulin sensitivity in men: an overview of the TELECOM study. In Vermeulon A, Oddens BJ, International Health Foundation (Eds), Androgens and the aging male (pp 85–102), Parthenon Publishing: New York.
Navarro D, Acosta A, Robles E, DÃaz C (2012) Hormone profile of menopausal women in Havana. MEDICC Rev 14(2)
Liu PY, Iranmanesh A, Nehra AX, Keenan DM, Veldhuis JD (2005a) Mechanisms of hypoandrogenemia in healthy aging men. Endocrinol Metab Clin North Am 34:935–955
Liu PY, Swerdloff RS, Veldhuis JD (2004) The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 89:4789–4796
Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Morley PM, Stauber PM, Vellas B, Baumgartner RN, Garry PJ. 1997. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab Clin Exp 46: 410–413.
Gray A, Berlin JA, McKinlay JB, Longcope C (1991) An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiol 44:671–684
Hamburger C, Halvorsen K, Pedersen J (1945) Assay of Androgenic substances in the urine of normal men and women. Acta Pharmacol Toxicol 1:129–140
Veldhuis JD (2008) Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women. Ageing Res Rev 7:189–208
Dahlman-Wright K, Cavailles V, Fuqua SA et al (2006) International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 58(4):773–781
Katzenellenbogen BS, Montano MM, Le Goff P et al (1995) Antiestrogens: mechanisms and actions in target cells. J Steroid Biochem Mol Biol 53:387–393
Heldring N, Pike A, Andersson S et al (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87(3):905–931
Mendelsohn ME, Karas RH (2010) Rapid progress for non-nuclear estrogen receptor signaling. J Clin Investig 120:2277–2279
Thornton MJ (2013) Estrogens and aging skin. Dermato-endocrinology 5:264–270
Vina J, Sastre J, Pallardo FV, Gambini J, Borras C (2006) Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res 40:1359–1365
Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC (1993) Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (Lond) 84:95–98
Greeves JP, Cable NT, Reilly T, Kingsland C (1999) Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci (Lond) 97(1):79–84
Naftolin F, Ryan KJ, Petro Z (1971) Aromatization of androstenedione by the diencephalon. J Clin Endocrinol Metab 33(2):368–370
Abney TO (1999) The potential roles of estrogens in regulating Leydig cell development and function: a review. Steroids 64(9):610–617
Campion JM, Maricic MJ (2003) Osteoporosis in men. Am Fam Physician 67:1521–1526
Riggs BL, Khosla S, Melton LJ 3rd. 1998. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13(5):763-773.
Novotny R, Davis J (2015) Growth in bone and body size among Asian and white girls in the Female Adolescent Maturation (FAM) study. Arch Osteoporos 10:31
Albright F, Smith PH, Richardson AM (1941) postmenopausal osteoporosis. JAMA 116:2465–2474
Lindsay R, Aitkin JM, Anderson JB, Hart DM, MacDonald EB, Clarke AC (1976) Long-term prevention of postmenopausal osteoporosis by oestrogen. Lanceti:1038–1040
Genant HK, Cann CE, Ettinger B, Gordan GS (1982) Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97:699–705
Riggs BL, Melton LJ (1986) Medical progress series: Involutional osteoporosis. N Engl J Med 314:1676–1686
Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84–86
Komm BS, Terpening CM, Benz DJ, Graeme KA, O’Malley BW, Haussler MR (1988) Estrogen binding receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81–84
Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC (1991) Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:6613–6617
Cosman F, Shen V, Xie F, Seibel M, Ratcliffe A, Lindsay R (1993) Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Ann Intern Med 118:337–343
Heaney RP, Recker RR, Saville PD (1978) Menopausal changes in calcium balance performance. J Lab Clin Med 92:953–963
McKane WR, Khosla S, Burritt MF, Kao PC, Wilson DM, Ory SJ, Riggs BL (1995) Mechanism of renal calcium conservation with estrogen replacement therapy in women in early post- menopause-A clinical research center study. J Clin Endocrinol Metab 80:3458–3464
Gennari C, Agnusdei D, Nardi P, Civitelli R (1990) Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women. J Clin Endocrinol Metab 71:1288–1293
Heshmati HM, Khosla S, Robins SP, Geller N, McAlister CA, Riggs BL (2002) Endogenous residual estrogen levels determine bone resorption even in late post-menopausal women. J Bone Miner Res 17:172–178
Garnero P, Sornay-Rendu E, Chapuy M, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337–349
Lips P, Courpron P, Meunier PJ (1978) Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 26:13–17
Marie PJ, de Vernejoul MC (1993) Proliferation of bone surface-derived osteoblastic cells and control of bone formation. Bone 14:463–468
Vermeulen A (1987) Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. J Clin Endocrinol Metab 64:884–888
Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg P, Bengtsson B (1994) Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 41:351–357
Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825–833
Murphy S, Khaw KT, Cassidy A et al (1993) Sex hormones and bone mineral density in elderly men. Bone Miner 20:133–140
Rucker D, Ezzat S, Diamandi A et al (2004) IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. Clin Endocrinol 60:491–499
Lorentzon M, Swanson C, Andersson N et al (2005) Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study. J Bone Miner Res 20:1334–1341
Jackson JA, Riggs MW, Spiekerman AM (1992) Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 304:4–8
Khosla S, Melton LJ 3rd, Atkinson EJ, et al. 2001. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 86: 3555–3561.
Smith EP, Boyd J, Frank GR et al (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056–1061
Carani C, Qin K, Simoni M et al (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91–95
Candow DG, Chilibeck PD (2005) Differences in size, strength, and power of upper and lower body muscle groups in young and older men. J Gerontol A Biol Sci Med Sci 60:148–156
Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(suppl):990–991
Lexell J (1995) Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci 50:11–16
Goodpaster BH, Park SW, Harris TB et al (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61:1059–1064
Baum K, Hildebrandt U, Edel K et al (2009) Comparison of skeletal muscle strength between cardiac patients and age-matched healthy controls. Int J Med Sci 6:184–191
Kalyani RR, Corriere M, Ferrucci L (2014) Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2:819–829
Maggio M, Ceda GP, Lauretani F et al (2011) Gonadal status and physical performance in older men. Aging Male 14:42–47
Boxer RS, Kenny AM, Dowsett R, Taxel P (2005) The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer. Aging Male 8:207–212
Bhasin S, Storer TW, Berman N et al (1996) The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335:1–7
Schroeder ET, He J, Yarasheski KE et al (2012) Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation. Eur J Appl Physiol 112:1123–1131
Aloia JF, McGowan DM, Vaswani AN, Ross P, Cohn SH (1991) Relationship of menopause to skeletal and muscle mass. Am J Clin Nutr 53:1378–1383
Rolland YM, Perry HM III, Patrick P, Banks WA, Morley JE (2007) Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. J Gerontol A Biol Sci Med Sci 62:330–335
Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G et al (2006) Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53:77–82
Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ (1999) Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 107:123–136
Wolfe RR, Miller SL, Miller KB (2008) Optimal protein intake in the elderly. Clin Nutr 27:675–684
Lord C, Chaput JP, Aubertin-Leheudre M, Labonte M, Dionne IJ (2007) Dietary animal protein intake: association with muscle mass index in older women. J Nutr Health Aging 11:383–387
Hiona A, Leeuwenburgh C (2008) The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging. Exp Gerontol 43:24–33
DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 Suppl):1689S–1696S
Holick MF. 1999. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams & Wilkins, Philadelphia, pp 92–98
Zanello SB, Collins ED, Marinissen MJ, Norman AW, Boland RL (1997) Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts. Horm Metab Res 29:231–236
Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stahelin HB et al (2001) In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 33:19–24
Calmels P, Vico L, Alexandre C, Minaire P (1995) Cross-sectional study of muscle strength and bone mineral density in a population of 106 women between the ages of 44 and 87 years: relationship with age and menopause. Eur J Appl Physiol Occup Physiol 70:180–186
Sitnick M, Foley AM, Brown M, Spangenburg EE (2006) Ovariectomy prevents the recovery of atrophied gastrocnemius skeletal muscle mass. J Appl Physiol 100:286–293
Wiik A, Ekman M, Johansson O, Jansson E, Esbjornsson M (2009) Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue. Histochem Cell Biol 131:181–189
Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG et al (2003) In vivo imaging of transcriptionally active estrogen receptors. Nat Med 9:82–86
Murphy LJ, Ghahary A (1990) Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 11:443–453
MacKay JD, Mensah GA (2004) The atlas of heart disease and stroke. WHO, Geneva
Jones RD, Pugh PJ, Hall J et al (2003) Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse. Eur J Endocrinol 148:111–120
Jones RD, Nettleship JE, Kapoor D et al (2005) Testosterone and atherosclerosis in aging men: purported association and clinical implications. Am J Cardiovasc Drugs 5:141–154
Hak AE, Witteman JC, de Jong FH et al (2002) Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 87:3632–3639
Haffner SM, Mykkanen L, Valdez RA et al (1993) Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. J Clin Endocrinol Metab 77:1610–1615
Van Pottelbergh I, Braeckman L, De Bacquer D et al (2003) Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. Atherosclerosis 166:95–102
Lichtenstein MJ, Yarnell JW, Elwood PC et al (1987) Sex hormones, insulin, lipids, and prevalent ischemic heart disease. Am J Epidemiol 126:647–657
Khaw KT, Barrett-Connor E (1988) Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens 6:329–332
Schirmer SH, Buschmann IR, Jost MM, Hoefer IE, Grundmann S, Andert JP, Ulusans S, Bode C, Piek JJ, van Royen N (2004) Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis. Cardiovasc Res 64:356–364
Kontoleon PE, Anastasiou-Nana MI, Papapetrou PD et al (2003) Hormonal profile in patients with congestive heart failure. Int J Cardiol 87:179–183
Tappler B, Katz M (1979) Pituitary-gonadal dysfunction in low-output cardiac failure. Clin Endocrinol 10:219–226
Noirhomme P, Jacquet L, Underwood M et al (1999) The effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failure. Eur J Cardiothorac Surg 16:63–67
Ahmed SA, Penhale WJ, Talal N (1985) Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121:531–551
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Writing group for the women’s health initiative investigators. JAMA 288:321–333
Hodis HN, Mack WJ (2002) Atherosclerosis imaging methods: assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis. Am J Cardiol 89:19E–27E. discussion 27E
Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH (1987) A prospective study of age at menarche, parity, age at first birth, and coronary heart disease in women. Am J Epidemiol 126:861–870
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:605–613
Genazzani AR, Petraglia F, Purdy RH (1996) The brain: source and target for sex steroid hormones. The Parthenon Publishing Group, Italy
Hebert LE, Beckett LA, Scherr PA, Evans DA (2001) Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 15:169–173
Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S (2002) The public health impact of Alzheimer’s disease, 2000–2050: potential implication of treatment advances. Annu Rev Public Health 23:213–231
Schumacher M, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F, Robel P, De N, Baulieu EE (2000) Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J Neurocytol 29:307–326
Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A (1998) Incidence and risk of dementia: the Rotterdam Study. Am J Epidemiol 147:574–580
Amouyel P (2002) Genetic susceptibility to aging-associated diseases. C R Biol 325:741–745
Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJM, GarciaSegura LM, Lambert JJ, Mayo W, Melcangi RC, Parducz A et al (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71:3–29
Baulieu EE (1997) Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52:1–32
Kruijver FP, Fernandez-Guasti A, Fodor M, Kraan EM, Swaab DF (2001) Sex differences in androgen receptors of the human mammillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. J Clin Endocrinol Metab 86:818–827
Beyer C (1999) Estrogen and the developing brain. Anat Embryol 199:379–390
Sherwin BB (1997) Estrogen effects on cognition in menopausal women. Neurology 48:S21–S26
Alonso-Soleis R, Abreu P, Leopez-Coviella I, Hernandez G, Fajardo N (1996) Gonadal steroid modulation of neuroendocrine transduction: a transynaptic view. Cell Mol Neurobiol (3):357–382
Keefe D, Garcia-Segura LM, Naftolin F (1994) New insights into estrogen action on the brain. Neurobiol Aging 15:495–497
Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138:4613–4621
Gruber CJ, Tschugguel W, Schneeberger C, Huber JC (2002) Production and actions of estrogens. N Engl J Med 346:340–352
Falkenstein E, Wehling M (2000) Nongenomically initiated steroid actions. Eur J Clin Invest 30(Suppl 3):51–54
Kuppers E, Ivanova T, Karolczak M, Lazarov N, Fohr K, Beyer C (2001) Classical and nonclassical estrogen action in the developing midbrain. Horm Behav 40:196–202
Phillips SM, Sherwin BB (1992a) Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485–495
Simerly RB, McCall LD, Watson SJ (1988) Distribution of opioid peptides in the preoptic region: immunohistochemical evidence for a steroidsensitive enkephalin sexual dimorphism. J Comp Neurol 276:442–459
Craft RM, Mogil JS, Aloisi AM (2004) Sex differences in pain and analgesia: the role of gonadal hormones. Eur J Pain 8:397–411
Genazzani AR, Stomati M, Bernardi F, Luisi S, Casarosa E, Puccetti S, Genazzani AD, Palumbo M, Luisi M (2004) Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats. Fertil Steril 81:757–766
Genazzani AR, Pluchino N, Luisi S, Luisi M (2007) Estrogen, cognition and female ageing. Hum Reprod Update 13:175–187
Genazzani AR, Petraglia F, Facchinetti F et al (1984) Increase of proopiomelanocortin-related peptides during subjective menopausal flushes. Am J Obstet Gynecol 149:775–779
Linghtman SL, Jacobs HS, Maguire AK (1981) Climateric flushing: clinical and endocrine response to infusion of naloxone. Br J Obstet Gynecol 88:919–924
Adler MW (1980) Minireview: opioid peptides. Life Sci 26:496–510
Reiter RJ (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 12:151–180
Reiter RJ (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56:359–384
Morioka N, Okatani Y, Wakatsuki A (1999) Melatonin protects against age-related DNA damage in the brains of female senescence-accelerated mice. J Pineal Res 27:202–209
Lewy AJ, Sack RL (1997) Exogenous melatonin’s phase-shifting effects on the endogenous melatonin profile in sighted humans: a brief review and critique of the literature. J Biol Rhythms 12:588–594
Zhdanova IV, Wurtman RJ (1997) Efficacy of melatonin as a sleep-promoting agent. J Biol Rhythms 12:644–650
Birau N, Peterssen U, Meyer C, Gottschalk J (1981) Hypotensive effect of melatonin in essential hypertension. IRSC Med Sci 9:906
Okatani Y, Morioka N, Wakatsuki A (2000) Changes in nocturnal melatonin secretion in peri-menopausal women. Correlation with endogenous estrogen concentrations. J Pineal Res 28:111–118
Alonso R, Abreu P, Fajardo N (1995) Ovarian hormones regulate α1- and β-adrenoceptor interactions in female rat pinealocytes. Neuroreport 6:345–348
Ponholzer A, Temml C, Mock K et al (2005) Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 47:80–85; discussion 85–86.
Shabsigh R, Anastasiadis AG (2003) Erectile dysfunction. Annu Rev Med 54:153–168
Kratzik CW, Schatzl G, Lunglmayr G et al (2005) The impact of age, body mass index and testosterone on erectile dysfunction. J Urol 174:240–243
Gray PB, Singh AB, Woodhouse LJ et al (2005) Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab 90:3838–3846
Aversa A, Isidori AM, Spera G et al (2003) Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf) 58:632–638
Shabsigh R, Kaufman JM, Steidle C et al (2004) Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172:658–663
Inoue T, Miki Y, Abe K, Hatori M, Hosaka M, Kariya Y et al (2011) The role of estrogen-metabolizing enzymes and estrogen receptors in human epidermis. Mol Cell Endocrinol 344:35–40
Brincat M, Versi E, Moniz CF, Magos A, de Trafford J, Studd JW (1987) Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 70:123–127
Brincat M, Moniz CJ, Studd JW, Darby A, Magos A, Emburey G et al (1985) Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 92:256–259
Affinito P, Palomba S, Sorrentino C, Di Carlo C, Bifulco G, Arienzo MP et al (1999) Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 33:239–247
Shah MG, Maibach HI (2001) Estrogen and skin. An overview. Am J Clin Dermatol 2:143–150
Emmerson E, Hardman MJ (2012) The role of estrogen deficiency in skin ageing and wound healing. Biogerontology 13:3–20
Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS et al (1997) Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 3:1209–1215
Lobo RA (2017) Hormone-replacement therapy: current thinking. Nat Rev Endocrinol 13:220–231
Siregar MFG (2015) Hormonal therapy for aging process in women. Int J Adv Med 2:83–87
Schwartz E, Holtorf K (2011) Hormone replacement therapy in the geriatric patient: current state of the evidence and questions for the future. Estrogen, progesterone, testosterone, and thyroid hormone augmentation in geriatric clinical practice: part 1. Clin Geriatr Med (4):542–559
López-OtÃn C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194–1217
Hulbert AJ, Pamplona R, Buffenstein R, Buttemer WA (2007) Life and death: metabolic rate, membrane composition, and life span of animals. Physiol Rev 87:1175–1213
Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359–407
Beckman KB, Ames BN (1998) Free radical theory of aging matures. Physiol Rev 78:547–581
Bokov A, Chaudhuri A, Richardson A (2004) The role of oxidative damage and stress in aging. Mech Ageing Devel 125:811–826
Hanukoglu I (2006) Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev 38:171–196
Nebert D, Dalton TP (2006) The role of cytochrome P450 enzymes in endogenous signaling pathways and environmental carcinogenesis. Nat Rev Cancer 6:947–960
Jackson MJ, Papa S, Bolaños J et al (2002) Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol Aspects Med 23:209–285
Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247
Stowe DF, Camara AKS (2008) Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function. Antioxid Redox Signal 11:1373–1414
Hornsby PJ (1989) Steroid and xenobiotic effects on the adrenal cortex: mediation by oxidative and other mechanisms. Free Radic Biol Med 6:103–115
Azhar S, Cao L, Reaven E (1995) Alteration of the adrenal antioxidant defense system during aging in rats. J Clin Invest 96:141424
Cao L, Leers-Sucheta S, Azhar S (2004) Aging alters the functional expression of enzymatic and non-enzymatic anti-oxidant defense systems in testicular rat Leydig cells. J Steroid Biochem Mol Biol 88:61–67
Vina J, Borras C, Gambini J, Sastre J, Pallardo FV (2005) Why females live longer than males: control of longevity by sex hormones. Sci Aging Knowl Environ (23):pe17
Acknowledgments
The RKT laboratory has been supported by research grants from the Government of India agencies including UPE-II, UGC (major), CSIR, DST, and ICMR. Central grants from ICMR-CAR, UGC-SAP, and DST-PURSE are also acknowledged. GB was supported by BioCaRE grant from DBT, India. Research in the BC laboratory was supported by Federal grants in the USA (VA-1I01BX000280 and VA-RCS (IK6BX004207); NIH-R01AG-10486; DOD-W81XWH-14-1-0606) and a Foundation grant from Morrison Trust, San Antonio, Texas.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Bagchi, G. et al. (2019). Sex Steroids, Cognate Receptors, and Aging. In: Rath, P. (eds) Models, Molecules and Mechanisms in Biogerontology. Springer, Singapore. https://doi.org/10.1007/978-981-13-3585-3_13
Download citation
DOI: https://doi.org/10.1007/978-981-13-3585-3_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3584-6
Online ISBN: 978-981-13-3585-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)